06:05 EDT Spyre Therapeutics files to sell 33.36M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYRE:
- Spyre Therapeutics price target raised to $54 from $36 at Stifel
- Spyre Therapeutics Secures $180M in Strategic Financial Move
- Spyre Therapeutics announces $180M private placement
- Spyre Therapeutics price target raised to $50 from $44 at Guggenheim
- GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls